Abstract # 2281 Bevacizumab in Combination with Androgen Deprivation and IMRT in Patients with High Risk Prostate Cancer

Presenter: Pham, Huong

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

To evaluate the toxicity and PSA response in patients treated on a phase II trial of bevacizumab in combination with androgen deprivation and IMRT for high risk prostate cancer.